Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922790 · ClinicalTrials.gov registry record · NA
Feasibility and Smokers' Reactions to DNA Feedback
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02922790 is a NA study that has completed, run by Duke University. The registered enrollment target is 39 participants.
The verdict
NCT02922790, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of the study is to explore how feedback of cellular DNA (Deoxyribonucleic Acid) damage, as a marker of exposure to the genotoxic agents of tobacco smoke, promotes cessation.
Interventions
- BEHAVIORAL standard health information
- BEHAVIORAL standard health information plus info. on DNA damage
- BEHAVIORAL Subjects will review standard health information and information on DNA damage, plus pictures of their DNA damage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2017-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922790
The ClinicalTrials.gov registry entry for NCT02922790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which standard health information is the first listed.
NCT02922790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02922790 about?
NCT02922790 is a clinical study titled "Feasibility and Smokers' Reactions to DNA Feedback". The purpose of the study is to explore how feedback of cellular DNA (Deoxyribonucleic Acid) damage, as a marker of exposure to the genotoxic agents of tobacco smoke, promotes cessation.
What is the current status of trial NCT02922790?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-02-14. Estimated completion is 2017-07-24.
What interventions are being tested in trial NCT02922790?
The interventions under investigation include: standard health information (BEHAVIORAL), standard health information plus info. on DNA damage (BEHAVIORAL), Subjects will review standard health information and information on DNA damage, plus pictures of their DNA damage (BEHAVIORAL).
Who is sponsoring clinical trial NCT02922790?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.